Moody Lynn & Lieberson, LLC Vertex Pharmaceuticals Inc Transaction History

Moody Lynn & Lieberson, LLC

$1.47 Billion
Q2 2024

A detailed history of Moody Lynn & Lieberson, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Moody Lynn & Lieberson, LLC holds 56,425 shares of VRTX stock, worth $28.1 Million. This represents 1.79% of its overall portfolio holdings.

Number of Shares

56,425

Previous 61,972 8.95%

Holding current value

$28.1 Million

Previous $25.9 Million 2.1%

% of portfolio

1.79%

Previous 1.8%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$392.81 - $485.53 $2.18 Million - $2.69 Million	-5,547 Reduced 8.95%	56,425 $26.4 Million
Q1 2024 Apr 23, 2024	BUY	$407.69 - $446.08 $1 Million - $1.1 Million	2,461 Added 4.14%	61,972 $25.9 Million
Q4 2023 Jan 24, 2024	SELL	$343.0 - $410.68 $3.46 Million - $4.14 Million	-10,090 Reduced 14.5%	59,511 $24.2 Million
Q3 2023 Oct 24, 2023	SELL	$338.18 - $362.46 $119,715 - $128,310	-354 Reduced 0.51%	69,601 $24.2 Million
Q2 2023 Jul 27, 2023	BUY	$314.42 - $351.91 $419,436 - $469,447	1,334 Added 1.94%	69,955 $24.6 Million

Q1 2023 May 02, 2023	SELL	$283.23 - $323.1 $53,247 - $60,742	-188 Reduced 0.27%	68,621 $21.6 Million
Q4 2022 Feb 01, 2023	BUY	$285.76 - $321.48 $5.55 Million - $6.24 Million	19,423 Added 39.33%	68,809 $19.9 Million
Q3 2022 Oct 26, 2022	BUY	$273.83 - $305.53 $7.8 Million - $8.7 Million	28,484 Added 136.27%	49,386 $14.3 Million
Q2 2022 Jul 28, 2022	BUY	$234.96 - $292.55 $533,124 - $663,795	2,269 Added 12.18%	20,902 $5.89 Million
Q1 2022 Apr 27, 2022	BUY	$221.42 - $260.97 $4.13 Million - $4.86 Million	18,633 New	18,633 $4.86 Million
Q3 2020 Oct 28, 2020	SELL	$255.65 - $303.1 $3.82 Million - $4.53 Million	-14,938 Closed	0 $0
Q2 2020 Jul 24, 2020	SELL	$225.48 - $295.8 $2.4 Million - $3.15 Million	-10,665 Reduced 41.66%	14,938 $4.34 Million
Q1 2020 Apr 30, 2020	SELL	$199.77 - $247.81 $112,270 - $139,269	-562 Reduced 2.15%	25,603 $6.09 Million
Q4 2019 Jan 28, 2020	BUY	$166.71 - $223.91 $4.36 Million - $5.86 Million	26,165 New	26,165 $5.73 Million
Q1 2018 Apr 27, 2018	SELL	$151.6 - $177.13 $3.58 Million - $4.19 Million	-23,640 Closed	0 $0
Q4 2017 Feb 02, 2018	BUY	$137.28 - $155.55 $3.25 Million - $3.68 Million	23,640	23,640 $3.94 Million

Others Institutions Holding VRTX

# of Institutions

1,656

Shares Held

222M

Call Options Held

1.35M

Put Options Held

1.49M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $128B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moody Lynn & Lieberson, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moody Lynn & Lieberson, LLC with notifications on news.

Account

Moody Lynn & Lieberson, LLC Vertex Pharmaceuticals Inc Transaction History